Yield10 Bioscience Statistics
Share Statistics
Yield10 Bioscience has 1.03M shares outstanding. The number of shares has increased by -94.51% in one year.
| Shares Outstanding | 1.03M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 2.27% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 537.50K |
| Failed to Deliver (FTD) Shares | 286 |
| FTD / Avg. Volume | 5.61% |
Short Selling Information
The latest short interest is 2.53K, so 0.37% of the outstanding shares have been sold short.
| Short Interest | 2.53K |
| Short % of Shares Out | 0.37% |
| Short % of Float | 0.47% |
| Short Ratio (days to cover) | 0.03 |
Valuation Ratios
The PE ratio is -0.13 and the forward PE ratio is -0.14.
| PE Ratio | -0.13 |
| Forward PE | -0.14 |
| PS Ratio | 31.67 |
| Forward PS | 0.3 |
| PB Ratio | -0.77 |
| P/FCF Ratio | -0.19 |
| PEG Ratio | n/a |
Enterprise Valuation
Yield10 Bioscience Inc. has an Enterprise Value (EV) of 47.72M.
| EV / Earnings | -3.3 |
| EV / Sales | 795.36 |
| EV / EBITDA | -3.38 |
| EV / EBIT | -3.31 |
| EV / FCF | -4.72 |
Financial Position
The company has a current ratio of 0.29, with a Debt / Equity ratio of -0.88.
| Current Ratio | 0.29 |
| Quick Ratio | 0.29 |
| Debt / Equity | -0.88 |
| Total Debt / Capitalization | -759.17 |
| Cash Flow / Debt | -4.59 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 5.82% and return on capital (ROIC) is -1996.81%.
| Return on Equity (ROE) | 5.82% |
| Return on Assets (ROA) | -3.7% |
| Return on Capital (ROIC) | -1996.81% |
| Revenue Per Employee | 2.07K |
| Profits Per Employee | -498.45K |
| Employee Count | 29 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -93.8% in the last 52 weeks. The beta is 1.43, so Yield10 Bioscience 's price volatility has been higher than the market average.
| Beta | 1.43 |
| 52-Week Price Change | -93.8% |
| 50-Day Moving Average | 0.54 |
| 200-Day Moving Average | 2.38 |
| Relative Strength Index (RSI) | 43.82 |
| Average Volume (20 Days) | 5.09K |
Income Statement
In the last 12 months, Yield10 Bioscience had revenue of 60.00K and earned -14.46M in profits. Earnings per share was -43.66.
| Revenue | 60.00K |
| Gross Profit | -230.00K |
| Operating Income | -14.42M |
| Net Income | -14.46M |
| EBITDA | -14.13M |
| EBIT | -14.42M |
| Earnings Per Share (EPS) | -43.66 |
Balance Sheet
The company has 1.07M in cash and 3.21M in debt, giving a net cash position of -2.14M.
| Cash & Cash Equivalents | 1.07M |
| Total Debt | 3.21M |
| Net Cash | -2.14M |
| Retained Earnings | -414.15M |
| Total Assets | 2.97M |
| Working Capital | -6.46M |
Cash Flow
In the last 12 months, operating cash flow was -10.07M and capital expenditures -46.00K, giving a free cash flow of -10.11M.
| Operating Cash Flow | -10.07M |
| Capital Expenditures | -46.00K |
| Free Cash Flow | -10.11M |
| FCF Per Share | -30.55 |
Margins
Gross margin is -383.33%, with operating and profit margins of -24.03K% and -24.09K%.
| Gross Margin | -383.33% |
| Operating Margin | -24.03K% |
| Pretax Margin | -24.09K% |
| Profit Margin | -24.09K% |
| EBITDA Margin | -23.55K% |
| EBIT Margin | -24.03K% |
| FCF Margin | -16.86K% |
Dividends & Yields
YTEN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -12841.18% |
| FCF Yield | -2927.69% |
Analyst Forecast
The average price target for YTEN is $12, which is 3429.4% higher than the current price. The consensus rating is "Hold".
| Price Target | $12 |
| Price Target Difference | 3429.4% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Stock Splits
The last stock split was on May 3, 2024. It was a backward split with a ratio of 1:24.
| Last Split Date | May 3, 2024 |
| Split Type | backward |
| Split Ratio | 1:24 |
Scores
| Altman Z-Score | -214.37 |
| Piotroski F-Score | 4 |